KLRK1 and head and neck squamous cell carcinoma: Researchers have discovered that exosomes isolated from the plasma of patients with HNSCC can reduce the expression level of Natural Killer Group 2 Member D (NKG2D) and inhibit the cytotoxicity of NK cells [28, 31–34].